Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG) [NA]
This clinical trial update reports that a confirmatory efficacy trial evaluating a gluten-free diet in people with schizophrenia who have hi…
-
FDA approval · 2025-06-11FDA Approved: OLANZAPINE INTRAMUSCULAR — Original Application (UBI Pharma Inc.)
The FDA approved the intramuscular olanzapine generic from UBI Pharma Inc. under an Original Application, for use in agitation associated wi…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Probing the Cannabinoid System in Individuals With a Family History of Psychosis [EARLY_Phase 1]
An early-phase 1 clinical trial conducted at Yale University to probe the cannabinoid system in individuals with a family history of psychos…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia [EARLY_Phase 1]
This entry notes an early Phase 1 trial at Peking University testing adjunctive thyroxine for avolition in schizophrenia, with the study not…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Peripheral Immune System in Individuals With Schizophrenia
This entry reports the completion of a Stanford University clinical trial studying the peripheral immune system in individuals with schizoph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Effectiveness of mHealth Post-discharge Intervention for Patients With Severe Mental Illness [NA]
This clinical trial update notes that enrollment is ongoing by invitation for a study evaluating a mobile health post-discharge intervention…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: The Effects of tDCS on Illness Awareness in Schizophrenia [NA]
The clinical trial evaluating transcranial direct current stimulation to improve illness awareness in schizophrenia has completed.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation [NA]
This clinical trial update describes a study to restore spindle activity and thalamocortical efficiency in early-course schizophrenia using …
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: App and Body Fat Scale in the Management of Overweight Patients [NA]
Trial status update for a study evaluating an app and body fat scale to manage overweight in patients with schizophrenia or bipolar disorder…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Toward a Computationally-Informed, Personalized Treatment for Hallucinations [EARLY_Phase 1]
An early-phase 1 study from Yale University is investigating a computationally-informed, personalized treatment for auditory hallucinations …
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2) [NA]
A clinical trial is actively recruiting to test whether neuromodulation can enhance brain connectivity in schizophrenia, sponsored by the Un…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental Disorders
This clinical trial update reports the completion of a survey examining reproductive and child-rearing situations among adults with severe m…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Efficacy of Hi-tACS for Schizophrenia Negative Symptoms [NA]
A clinical trial is recruiting to assess the efficacy of Hi-tACS (transcranial alternating current stimulation) for negative symptoms in sch…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia [Phase 1]
Phase 1 trial update describing a proposal to develop a rapid, cost-effective diagnostic test for schizophrenia; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia [Phase 2]
A Phase 2 trial evaluating focused ultrasound modulation of the globus pallidus interna for schizophrenia has completed, and results have be…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Deep Brain Stimulation for Psychosis [NA]
A clinical trial update notes that recruitment is underway for deep brain stimulation as a treatment for psychosis in treatment-refractory s…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Baduanjin on Patients With Schizophrenia [NA]
A completed clinical trial evaluating Baduanjin, a traditional Chinese exercise, in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects [Phase 1]
This Phase 1 clinical trial update reports on the safety and tolerability of LY03020 in Chinese healthy subjects and indicates the study has…
-
FDA approval · 2025-05-27FDA Approved: ASENAPINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for asenapine submitted by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder [Phase 4]
Phase 4 controlled trial results for brexpiprazole in patients with schizophrenia and co-occurring substance use disorder; results have been…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Ningbo Schizophrenia Cohort
The Ningbo Schizophrenia Cohort trial is listed as active but not recruiting participants.
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: iTBS to Enhance Social Cognition in People With Psychosis [NA]
A clinical trial is testing whether intermittent theta-burst stimulation (iTBS) can improve social cognition in people with psychosis, inclu…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination [NA]
This clinical trial entry describes an ongoing study evaluating whether transcranial direct current stimulation (tDCS)–mediated neuroplastic…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating metabolic effects of adjunctive lumateperone in clozapine-treated patients with schizophrenia is currently…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017 [Phase 1]
This is a Phase 1 MAD study to evaluate the safety, tolerability and pharmacokinetics of LY03017, with the trial sponsored by Luye Pharma Gr…